Open access
Loss of MSH6 or MSH2 sensitizes progressive glioblastoma to radiotherapy
Vlad Moisoiu
Roxanne Lourman
Frank Szulzewsky
T. Kessler
Giulio Collotta
Antonio Porro
A. Bertolini
F. Singer
P. Cimino
Caroline Hertler
W. Wick
G. Reifenberger
E. Holland
A. Sartori
Michael Weller
H. Wirsching
Medicine
Abstract
<strong>A prime resistance mechanism of glioblastoma to temozolomide is a vulnerability to radiation therapy</strong>